Cargando…

Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy

Detalles Bibliográficos
Autores principales:	Lin, Ming, Chang, Alfred E., Wicha, Max, Li, Qiao, Huang, Shiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800506/ https://www.ncbi.nlm.nih.gov/pubmed/29423335 http://dx.doi.org/10.4172/2157-7560.1000371

Ejemplares similares

Targeting cancer stem cells via dendritic-cell vaccination
por: Teitz-Tennenbaum, Seagal, et al.
Publicado: (2012)

Promise of cancer stem cell vaccine
por: Zhou, Li, et al.
Publicado: (2015)

Targeting cancer stem cells via integrin β4
por: Dobson, Hannah E., et al.
Publicado: (2021)

Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells
por: Lu, Lin, et al.
Publicado: (2015)

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
por: Li, Qiao, et al.
Publicado: (2014)

Characterization of a Novel Transgenic Mouse Tumor Model for Targeting HER2+ Cancer Stem Cells
por: Wang, Su He, et al.
Publicado: (2013)

Metabolic plasticity of cancer stem cells
por: Luo, Ming, et al.
Publicado: (2015)

Cancer stem cell heterogeneity in hereditary breast cancer
por: Wicha, Max S
Publicado: (2008)

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer
por: Wicha, Max S
Publicado: (2009)

Chemokines and cellular plasticity of ovarian cancer stem cells
por: Zou, Weiping, et al.
Publicado: (2015)

Migratory gene expression signature predicts poor patient outcome: Are cancer stem cells to blame?
por: Wicha, Max S
Publicado: (2012)

The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness
por: Ma, Yuxi, et al.
Publicado: (2021)

Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesis
por: Wicha, Max S
Publicado: (2006)

Mammary stem cell number as a determinate of breast cancer risk
por: Ginestier, Christophe, et al.
Publicado: (2007)

Biological and clinical significance of cancer stem cell plasticity
por: Zhu, Yongyou, et al.
Publicado: (2014)

Stem cells in human breast development and cancer
por: Wicha, M, et al.
Publicado: (2005)

Immunotherapy targeting esophageal cancer stem cells
por: Yue, Dongli, et al.
Publicado: (2013)

Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine
por: Wu, Di, et al.
Publicado: (2015)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Clinical Trial Design for Testing the Stem Cell Model for the Prevention and Treatment of Cancer
por: Reddy, Rishindra M., et al.
Publicado: (2011)

Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response
por: Sehl, Mary E., et al.
Publicado: (2015)

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer
por: Sun, Lichao, et al.
Publicado: (2016)

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
por: Lee, Eunmi, et al.
Publicado: (2019)

Are ovarian cancer stem cells the target for innovative immunotherapy?
por: Wang, Liang, et al.
Publicado: (2018)

Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
por: Badrinath, Narayanasamy, et al.
Publicado: (2019)

Gastrointestinal cancer stem cells as targets for innovative immunotherapy
por: Chivu-Economescu, Mihaela, et al.
Publicado: (2020)

Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma
por: Dai, Xiaomeng, et al.
Publicado: (2021)

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy
por: Wolfson, Benjamin, et al.
Publicado: (2021)

Inhibition of FAK kinase activity preferentially targets cancer stem cells
por: Kolev, Vihren N., et al.
Publicado: (2017)

Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012)

Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer
por: Szaryńska, Magdalena, et al.
Publicado: (2018)

Are Cancer Stem Cells a Suitable Target for Breast Cancer Immunotherapy?
por: Ruiu, Roberto, et al.
Publicado: (2022)

The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
por: Yang, Muyue, et al.
Publicado: (2020)

Application of ZnO-Based Nanocomposites for Vaccines and Cancer Immunotherapy
por: Sharma, Prashant, et al.
Publicado: (2019)

In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy
por: Chariou, Paul L., et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

Hybrid Stem Cell States: Insights Into the Relationship Between Mammary Development and Breast Cancer Using Single-Cell Transcriptomics
por: Thong, Tasha, et al.
Publicado: (2020)

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin
por: McDermott, Sarah C., et al.
Publicado: (2018)

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer
por: Liu, Mingshan, et al.
Publicado: (2018)

Tumor-associated carbohydrates and immunomodulatory lectins as targets for cancer immunotherapy
por: Rodrigues Mantuano, Natalia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tpo3fgfv2pi17122bdnv7m90eu